Estate of McLendon v. Commissioner

135 F.3d 1017
CourtCourt of Appeals for the Fifth Circuit
DecidedMarch 10, 1998
Docket97-60135
StatusPublished
Cited by29 cases

This text of 135 F.3d 1017 (Estate of McLendon v. Commissioner) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Estate of McLendon v. Commissioner, 135 F.3d 1017 (5th Cir. 1998).

Opinion

E. GRADY JOLLY, Circuit Judge:

The only question remaining in this appeal 1 is whether Gordon B. McLendon was sufficiently close to death on March 5, 1986, to require him to depart from the actuarial tables published by the Commissioner of Internal Revenue (the “Commissioner”) in valuing a remainder interest and related annuity. The Tax Court determined that he was, from which final decision McLendon’s Estate appeals. We reverse.

I

Although this ease raises several contentious legal questions, the underlying facts are not in serious dispute. Through various partnership interests, McLendon was the principal owner and director of a vast broadcasting and entertainment empire. His interests ranged from the 458-station Liberty Broadcasting System to numerous individual radio stations, television stations, and movie theaters. Over his life time, McLendon became a very wealthy man.

Mortality hovers over the castle as well as the cottage, however, and in May 1985 McLendon was diagnosed with esophageal cancer. Although his condition initially improved following radiation therapy, the cancer recurred in September. At this point, McLendon’s cancer was categorized as “systemic” — the most severe of three types of cancer growth. There is no dispute that the cancer was very likely terminal from this point forward, with a 2-3% overall survival rate. In particular, any remissions achieved after this point were generally expected by McLendon’s doctors to be temporary.

Nonetheless, from October 1985 through March 1986, McLendon received six courses of chemotherapy at M.D. Anderson’s world-renowned cancer treatment facility in Houston, Texas. On December 3, 1985, after three courses of chemotherapy, McLendon’s doctor wrote on his discharge summary:

The patient had an esophagogastroduode-noscopy on November 26, 1985, and it showed complete endoscopic remission *1019 confirmed by multiple biopsies of the affected area.

Despite this upbeat news, on December 5, 1985, McLendon attempted suicide by shooting himself in the head with a handgun. A suicide note reflected his belief that he would eventually succumb to the cancer and his desire not to prolong the suffering of his family. After being hospitalized for over a month for treatment of injuries from the failed suicide, McLendon began a fourth course of chemotherapy. He returned home in late January 1986 and began to receive periodic in-home examinations and treatment from a Dr. Gruebel. Her impression at the time was that he was doing well.

In early February, McLendon fell at home and was admitted to the hospital for treatment of his injuries. On February 14, while hospitalized, McLendon purportedly dictated 2 a letter to Dr. Freireich, his oncologist, which evidenced a renewed sense of confidence. McLendon stated that he was feeling much better even though the chemotherapy was “very, very debilitating.” Stating that he was “beginning to make plans for the rest of [his] life,” McLendon inquired specifically about his “total remission” and prognosis for the future, and asked whether he could “make long term plans.” Dr. Freireich responded on February 19. Advising against further surgical procedures, he noted:

The objective evidence that we have has failed to demonstrate any residual disease. This includes endoscopy with biopsies of the esophagus which have proven to be negative on several occasions and the repeated x-ray examinations by CT scan which fail to reveal any evidence of residual malignancy. [By] clinical and laboratory objective criteria, the present condition of your illness must be characterized as “complete remission.” The word remission is used advisedly, because the risk of recurrence is still much in the picture. On the other hand patients who are cured of their disease are exclusively drawn from the population of patients who have a “complete remission.” To state that positively, you are certainly a candidate for long term control which fulfills medical and lay criteria for curability. Unfortunately the maturity and quantity of our clinical data does not permit good estimates of the risk of recurrence in your specific instance. It is therefore necessary for me as a physician, to advise you of the risk that the disease might recur, but to state frankly and without hesitation that the possibility that your disease has been permanently eradicated is definite and significant and in my professional opinion, should form the basis for your planning for the future.

At the end of February, McLendon returned home under twenty-four hour care from a staff of private duty nurses. Notes taken by these nurses show that during the period from March 2 through March 5, McLendon was able to take short walks and perform minor tasks, but was at times sick to his stomach, was in constant need of pain medication, and was receiving artificial sustenance to ensure proper caloric intake. McLendon was examined at home on March 5 by the optimistic Dr. Gruebel. It was her impression at that time that McLendon was “markedly improved” and in the best condition since he had come into her care in January. The Commissioner subsequently presented undisputed expert testimony, however, that McLendon’s chances of surviving for more than one year from this date were approximately 10 percent. This estimate was based principally on the likelihood of recurrence in a case like McLendon’s.

On March 5, McLendon entered into a private annuity transaction with his son and the newly minted McLendon Family Trust. This transaction involved the transfer of remainder interests in McLendon’s partnership holdings to his son and the Trust in exchange for $250,000 and an annuity to be paid to McLendon for life. The amount of the annuity was set such that its aggregate present value would equal the present value of the remainder interests. In valuing the remainder interests and the annuity, the parties referred to the Commissioner’s actuarial ta *1020 bles for life expectancy then contained in Treas. Reg. § 25.2512-5(f). McLendon was sixty-five years old on March 5, 1986, resulting in an actuarial life expectancy of fifteen years from that date. Based on this figure, the parties ultimately determined that the remainder interests had a value of $5,881,-695, 3 and that the annuity would need to be $865,332 in order to match.

In late March, McLendon completed his final course of chemotherapy. In May, tests revealed a major recurrence of the cancer. Treatments were discontinued within a few weeks, and McLendon died at home on September 14. From the time that he was first admitted to M.D. Anderson in October 1985 until his death, McLendon survived longer than 75% of patients diagnosed with esophageal cancer.

II

McLendon’s estate tax return relied on a presumption that he had received an adequate and full consideration for the assets transferred in the private annuity transaction. The Commissioner disagreed with this presumption, taking issue with both the use of the actuarial tables and certain substantive aspects of the valuation of the partnership interests.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estate of Kite v. Comm'r
2013 T.C. Memo. 43 (U.S. Tax Court, 2013)
Kornman & Associates, Inc. v. United States
527 F.3d 443 (Fifth Circuit, 2008)
St. David's Health Care System v. United States
349 F.3d 232 (Fifth Circuit, 2003)
Vons Companies, Inc. v. United States
55 Fed. Cl. 709 (Federal Claims, 2003)
Rauenhorst v. Comm'r
119 T.C. No. 9 (U.S. Tax Court, 2002)
Gerald A. and Henrietta v. Rauenhorst v. Commissioner
119 T.C. No. 9 (U.S. Tax Court, 2002)
Brashear v. United States
138 F. Supp. 2d 786 (N.D. Texas, 2001)
Estate of Harrison v. Commissioner
115 T.C. No. 13 (U.S. Tax Court, 2000)
Estate of Judith U. Harrison v. Commissioner
115 T.C. No. 13 (U.S. Tax Court, 2000)
Dominion Resources, Incorporated v. United States
219 F.3d 359 (Fourth Circuit, 2000)
TelecomUSA, Inc. v. United States
192 F.3d 1068 (D.C. Circuit, 1999)
Telecom USA Inc v. United States
192 F.3d 1068 (D.C. Circuit, 1999)
Martinez v. CIR
Fifth Circuit, 1999
American Stores Co. v. Commissioner
170 F.3d 1267 (Tenth Circuit, 1999)
Dav-Con, Inc. v. State Board of Tax Commissioners
702 N.E.2d 1137 (Indiana Tax Court, 1998)
Street v. Commissioner
152 F.3d 482 (Fifth Circuit, 1998)
Delaune v. United States
143 F.3d 995 (Fifth Circuit, 1998)
United States v. Cluck
Fifth Circuit, 1998

Cite This Page — Counsel Stack

Bluebook (online)
135 F.3d 1017, Counsel Stack Legal Research, https://law.counselstack.com/opinion/estate-of-mclendon-v-commissioner-ca5-1998.